The Future of Marijuana Gum
Professor John Zajicek, who runs the marijuana gum clinical trials warns that it may be a while before the gum hits the market. Side-effects have been reported and are not well enough understood. It also lacks the lack of a “peak” high typical in traditional cannabis medicines.
Like any medicine, the gum will only be commercially available once it has been extensively tested and proven both safe and effective.
Current Cannabis Products
Current marijuana options for fibromyalgia sufferers include CBD hemp oil, which is low in the psychoactive THC compound also found in cannabis. It can be made at home or purchased in pure CBD-hemp oil form, diluted tinctures, capsules, and topicals (6).
Other options include smoking marijuana, which helps with chronic pain, insomnia, and more. It also allows for a more personalized treatment thanks to the many varieties of cannabis available only in bud form (7).
Cannabis gum’s possibilities don’t end there: AXIM Biotechnologies, Inc., major investment company, and the University of British Columbia have entered into a Clinical Study Agreement (CSA) to start a clinical trial for its CanChew Plus® cannabidiol (CBD) chewing gum. This gum is specifically created to treat adult drug-induced psychosis, also called a “substance-induced psychotic disorder”(9).
The ethics board of the University will design the trial alongside Health Canada to test the gum, which contains 50mg CBD. This is just one example of how cannabis products can be used for a multitude of illnesses.